# Ally Therapeutics, Inc. — Form D

Ally Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-09. The offering totals $11.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-08-09
- Form: D
- Accession: 0001785017-19-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $10.0M
- Remaining: $1.0M
- Investors: 3
- Date of first sale: 2019-07-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-346178

## Issuer

- Name: Ally Therapeutics, Inc.
- CIK: 0001785017
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 325 VASSAR STREET, CAMBRIDGE, MA, 02139
- Phone: 617-526-6000

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Steve Gillis | Director | New York, NY |
| Tina Liu | Director | New York, NY |
| Bob More | Director | Venice, CA |
| Erica Whittaker | Director | South San Francisco, CA |
| David Cordo | Executive Officer | Cambridge, MA |
| Tina Liu | Executive Officer | New York, NY |

## More

- [CIK 1785017 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1785017&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001785017-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.